New York State Common Retirement Fund’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

New York State Common Retirement Fund’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,000	Closed	-$43K	–	3236
2018 Q1	$43K	Hold	4,000	–	–	﹤0.01%	3039
2017 Q4	$169K	Hold	4,000	–	–	﹤0.01%	2831
2017 Q3	$220K	Hold	4,000	–	–	﹤0.01%	2727
2017 Q2	$742K	Buy	4,000 +862	+27%	+$151K	﹤0.01%	2211
2017 Q1	$375K	Hold	3,138	–	–	﹤0.01%	2513
2016 Q4	$312K	Hold	3,138	–	–	﹤0.01%	2595
2016 Q3	$351K	Hold	3,138	–	–	﹤0.01%	2502
2016 Q2	$322K	Buy	3,138 +1,525	+95%	+$152K	﹤0.01%	2489
2016 Q1	$148K	Hold	1,613	–	–	﹤0.01%	2806
2015 Q4	$233K	Buy	+1,613	New	+$210K	﹤0.01%	2689

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New York State Common Retirement Fund's SIOX Position: Q2 2018 in Review

New York State Common Retirement Fund sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 4,000 shares — an estimated $43K sold.

New York State Common Retirement Fund first reported a position in SIOX in Q4 2015 and held it in 10 quarters. The position peaked at $742K in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

New York State Common Retirement Fund reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
New York State Common Retirement Fund sold 4,000 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $43K.
New York State Common Retirement Fund first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 10 quarters.
New York State Common Retirement Fund's Sio Gene Therapies Inc. Common Stock position peaked at $742K in Q2 2017.
71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on New York State Common Retirement Fund's 13F filing for Q2 2018, filed 10 Aug 2018.